| Literature DB >> 22115838 |
Katsushi Kumata1, Masanao Ogawa, Makoto Takei, Masayuki Fujinaga, Yuichiro Yoshida, Nobuki Nengaki, Toshimitsu Fukumura, Kazutoshi Suzuki, Ming-Rong Zhang.
Abstract
Dantrolene (1) is a substrate for breast cancer resistant protein, which is widely distributed in the blood-brain-barrier, intestine, gall bladder, and liver. PET study with 1 labeled with a positron emitter can be used to visualize BCRP and to elucidate the effect of BCRP on the pharmacokinetics of drugs. The objective of this study was to label 1 using nitrogen-13 ((13)N, a positron emitter; half-life: 9.9min). Using no-carrier-added [(13)N]NH(3) as the labeling agent, we synthesized [(13)N]dantrolene ([(13)N]1) for the first time. The reaction of carbomyl chloride 2b with [(13)N]NH(3) gave an unsymmetrical urea [(13)N]3, followed by cyclization of [(13)N]3 to afford [(13)N]1. Due to its instability, 2b was prepared in situ by treating amine 5 with triphosgene in a ratio of 4 to 1 and used for subsequent [(13)N]ammonolysis without purification.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22115838 DOI: 10.1016/j.bmc.2011.10.077
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641